CIBC analyst Mark Jarvi downgrades TransAlta Renewables (TSX:RNW) from Outperformer to Neutral.
Alaunos Therapeutics Touts Early Clinical Response For Its Cancer Cell Therapy
Alaunos Therapeutics Inc (NASDAQ:TCRT) announced early clinical findings from its ongoing TCR-T Library Phase 1/2 trial. “We are excited to announce…